News Detail

17 Oct 2017 12:58:00
The Resolutions of the Board of Directors Meeting, The Set Date of the EGM No.1/2017. (Revise)
Full Detailed News
Download Full Detailed News
                Meeting schedule of securities holders

Subject                                  : Schedule of Extra-General Meeting of 
Date of Board resolution                 : 16-Oct-2017
Meeting date                             : 21-Nov-2017
Beginning time of meeting (h:mm)         : 14 : 00
Record date for the right to attend the  : 30-Oct-2017
Ex-meeting date                          : 25-Oct-2017
Significant agenda item                  :
  - 1. To consider and approve  the amendment of the  exercise price and the 
exercising period of  ESOP-W2 in the amount  not  exceeding  300,000,000 shares
to directors, managers, and employees of the Company and/or Subsidiaries at the
price of Baht 0 (Zero Baht)  per unit.
2. To consider and approve the allotment of  ESOP-W2  to  directors, managers, 
and employees of the Company and/or Subsidiaries.
3. To consider and approve the amendment of Article 4 and 5 of the Company 
regulations .
4. To consider and approve to the addition of the Company's objective and the 
amendment of Article 3 of the Company's Memorandum of Association to comply with
 the changing of the objective.
Venue of the meeting                     : the conference room, 9th Floor 
(Building 4), Vibhavadi Hospital, 1000 Vibhavadi Road, Ladyao, Jatujak, Bangkok
This announcement was prepared and disseminated by listed company or issuer 
through the electronic system which is provided for the purpose of dissemination
of the information and related documents of listed company or issuer to the
Stock Exchange of Thailand only.  The Stock Exchange of Thailand has   no
responsibility for the correctness and completeness of any statements, figures,
reports or opinions contained in this announcement, and has no liability for any
losses and damages in any cases.  In case you have any inquiries or
clarification regarding this announcement, please directly contact listed
company or issuer who made this announcement.